Movimientos anormales y embarazo

dc.creatorPalacios, Eduardo
dc.creatorNavas, Ángela Viviana
dc.date.accessioned2016-06-01 00:00:00
dc.date.accessioned2022-02-21T20:33:42Z
dc.date.accessioned2022-09-27T12:42:10Z
dc.date.available2016-06-01 00:00:00
dc.date.available2022-02-21T20:33:42Z
dc.date.available2022-09-27T12:42:10Z
dc.date.created2016-06-01 00:00:00
dc.date.created2022-02-21T20:33:42Z
dc.date.issued2016-06-01
dc.identifier0121-7372
dc.identifierhttps://repositorio.fucsalud.edu.co/handle/001/2062
dc.identifier2462-991X
dc.identifierhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/86
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3596612
dc.languagespa
dc.publisherSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.relationLee KA, Zaffke ME, Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: The role of folate and iron. J Womens Health Gend Based Med. 2001;10(4):335–41.
dc.relationManconi M, Govoni V, de Vito A, Economou NT, Cesnik E, Casetta I, et al. Restless legs syndrome and pregnancy. Neurology. 2004;63(6):1065–9.
dc.relationAllen RP, Earley CJ. Restless legs syndrome: A review of clinical and pathophysiologic features. J Clin Neurophysiol. 2001;18(2):128–47.
dc.relationChokroverty S. Sleep disorders. En: Bradley WG, Daroff RB, Fenechel GM, Jankovic J, editores. Neurology in cinical practice. 3rd ed. Woburn: Butterworth-Heinemann; 2000. p. 1781–827.
dc.relationSahota PK, Jain SS, Dhand R. Sleep disorders in pregnancy. Curr Opin Pulm Med. 2003;9(6):477–83.
dc.relationO’Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing. 1994;23(3):200–3.
dc.relationWinkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis. 1996;28(3):372–8.
dc.relationIannaccone S, Zucconi M, Marchettini P, Ferini-Strambi L, Nemni R, Quattrini A, et al. Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov Disord. 1995;10(1):2–9.
dc.relationMinagar A. Neurological disorders and pregnancy. Amsterdam: Elsevier; 2011. p. 205.
dc.relationEarley CJ. Clinical practice. Restless legs syndrome. N Engl J Med. 2003;348(21):2103–9.
dc.relationHening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep. 1999;22(7):970–99.
dc.relationChesson AL Jr, Wise M, Davila D, Johnson S, Littner M, Anderson WM, et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep. 1999;22(7):961–8.
dc.relationEkbom KA. Restless legs syndrome. Neurology. 1960;10:868–73.
dc.relationWilson P, Preece AA. Chorea gravidarum. Arch Intern Med. 1932;49:471–533.
dc.relationCardoso F. Chorea gravidarum. Arch Neurol. 2002;59(5):868–70.
dc.relationKranick SM, Mowry EM, Colcher A, Horn S, Golbe LI. Movement disorders and pregnancy: A review of the literature. Mov Disord. 2010;25(6):665–71.
dc.relationPalanivelu LM. Chorea gravidarum. J Obstet Gynaecol. 2007;27(3):310.
dc.relationDonaldson JO. Neurologic emergencies in pregnancy. Obstet Gynecol Clin North Am. 1991;18(2):199–212.
dc.relationIchikawa K, Kim RC, Givelber H, Collins GH. Chorea gravidarum. Report of a fatal case with neuropathological observations. Arch Neurol. 1980;37(7):429–32.
dc.relationPatterson JF. Treatment of chorea gravidarum with haloperidol. South Med J. 1979;72(9):1220–1.
dc.relationMiller LJ. Clinical strategies for the use of psychotropic drugs during pregnancy. Psychiatr Med. 1991;9(2):275–98.
dc.relationBriggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. Baltimore: Williams & Wilkins; 1994. p. 975.
dc.relationDike GL. Chorea gravidarum: A case report and review. Md Med J. 1997;46(8):436–9.
dc.relationAuerbach JG, Hans SL, Marcus J, Maeir S. Maternal psychotropic medication and neonatal behavior. Neurotoxicol Teratol. 1992;14(6):399–406.
dc.relationSexson WR, Barak Y. Withdrawal emergent syndrome in an infant associated with maternal haloperidol therapy. J Perinatol. 1989;9(2):170–2.
dc.relationCommittee on, Drugs, American Academy of Pediatrics. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Pediatrics. 2000;105(4):880–7.
dc.relationSmith MS, Evatt ML. Movement disorders in pregnancy. Neurol Clin. 2004;22(4):783–98.
dc.relationLesca G, Goizet C, Durr A. Predictive testing in the context of pregnancy: Experience in Huntington’s disease and autosomal dominant cerebellar ataxia. J Med Genet. 2002;39(7):522–5.
dc.relationQuinn N, Schrag A. Huntington’s disease and other choreas. J Neurol. 1998;245(11):709–16.
dc.relationAltshuler LL, Szuba MP. Course of psychiatric disorders in pregnancy. Dilemmas in pharmacologic management. Neurol Clin. 1994;12(3):613–35.
dc.relationMiller LJ. Psychiatric medication during pregnancy: Understanding and minimizing risks. Psychiatr Ann. 1994;24(2):69–75.
dc.relationMacKenzie WE. Pregnancy in women with Friedreich’s ataxia. Br Med J (Clin Res Ed). 1986;293(6542):308.
dc.relationBerardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD. The pathophysiology of primary dystonia. Brain. 1998;121 Pt 7:1195–212.
dc.relationHallett M. The neurophysiology of dystonia. Arch Neurol. 1998;55(5):601–3.
dc.relationWatts RL, Koller WC. Movement disorders: Neurologic principles and practice. New York: McGrawHill; 1997. p. 779.
dc.relationBressman SB, de Leon D, Brin MF, Risch N, Burke RE, Greene PE, et al. Idiopathic dystonia among Ashkenazi Jews: Evidence for autosomal dominant inheritance. Ann Neurol. 1989;26(5):612–20.
dc.relationRoutiot T, Lurel S, Denis E, Barbarino-Monnier P. [Parkinson’s disease and pregnancy: Case report and literature review]. J Gynecol Obstet Biol Reprod (Paris). 2000;29(5):454–7.
dc.relationSawada H, Ibi M, Kihara T, Honda K, Nakamizo T, Kanki R, et al. Estradiol protects dopaminergic neurons in a MPP + Parkinson’s disease model. Neuropharmacology. 2002;42(8):1056–64.
dc.relationFishman J. Biological action of catechol oestrogens. J Endocrinol. 1981;89 Suppl:59P–65P.
dc.relationHagell P, Odin P, Vinge E. Pregnancy in Parkinson’s disease: A review of the literature and a case report. Mov Disord. 1998;13(1):34–8.
dc.relationDostal M, Weber-Schoendorfer C, Sobesky J, Schaefer C. Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: A case series. Eur J Neurol. 2013;20(9):1241e6.
dc.relationJacquemard F, Palaric JC, Allain H, Giraud JR. Parkinson disease and pregnancy. Apropos of a case. J Gynecol Obstet Biol Reprod (Paris). 1990;19:461e3.
dc.relationSethi Kapil D, Tremor. Curr Opin Neurol. 2003;16(4):481–5.
dc.relationTanner CM, Goldman SM. Epidemiology of movement disorders. Curr Opin Neurol. 1994;7(4):340–5.
dc.relationHubble JP, Busenbark KL, Koller WC. Essential tremor. Clin Neuropharmacol. 1989;12(6):453–82.
dc.relationhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/86/72
dc.relationNúm. 2 , Año 2016 : Abril – Junio
dc.relation105
dc.relation2
dc.relation101
dc.relation25
dc.relationRevista Repertorio de Medicina y Cirugía
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightsFundación Universitaria de Ciencias de la Salud-FUCS - 2016
dc.sourcehttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/86
dc.subjectMovimientos anormales
dc.subjectEmbarazo
dc.subjectCorea gravidarum
dc.subjectAbnormal movements
dc.subjectPregnancy
dc.subjectChorea gravidarum
dc.titleMovimientos anormales y embarazo
dc.typeArtículo de revista
dc.typeJournal article


Este ítem pertenece a la siguiente institución